The Technical Analyst
Select Language :
Poseida Therapeutics, [PSTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Poseida Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Poseida Therapeutics, is listed at the  Exchange

3.57% $3.19

America/New_York / 28 mar 2024 @ 16:00


Poseida Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 307.80 mill
EPS: -1.370
P/E: -2.33
Earnings Date: May 07, 2024
SharesOutstanding: 96.49 mill
Avg Daily Volume: 0.744 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.33 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.40x
Company: PE -2.33 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.0078
(-100.24%) $-3.20
Date: 2024-03-28
Expected Trading Range (DAY)

$ 2.83 - 3.54

( +/- 11.16%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-01 Mylet Johanna Buy 80 743 Common Stock
2024-03-01 Mylet Johanna Sell 18 091 Common Stock
2024-03-01 Mylet Johanna Buy 111 700 Employee Stock Option (Right to Buy)
2024-03-01 Gergen Mark J Sell 34 157 Common Stock
2024-03-01 Leonhardt Harry J Buy 80 743 Common Stock
INSIDER POWER
87.31
Last 93 transactions
Buy: 8 975 230 | Sell: 550 582

Forecast: 16:00 - $3.18

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.18
Forecast 2: 16:00 - $3.18
Forecast 3: 16:00 - $3.18
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.19 (3.57% )
Volume 0.690 mill
Avg. Vol. 0.744 mill
% of Avg. Vol 92.78 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Poseida Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Poseida Therapeutics, Inc.

RSI

Intraday RSI14 chart for Poseida Therapeutics, Inc.

Last 10 Buy & Sell Signals For PSTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$3.39N/AActive
Profile picture for
            Poseida Therapeutics, Inc.

PSTX

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
PROPCUSDMar 28 - 18:585.09
XCADUSDMar 28 - 18:571.490
INDEXUSDMar 28 - 18:565.95
FUMOUSDMar 28 - 18:5410 001
ALPHUSDMar 28 - 18:542.71
HNTUSDMar 28 - 18:47$6.19
WBTUSDMar 28 - 18:438.37
TRXUSDMar 28 - 18:39$0.120
XMRUSDMar 28 - 18:34$135.06
IONUSDMar 28 - 18:23454.85

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.